Publicacions en què col·labora amb Rodrigo José Carbajo Martínez (29)

2015

  1. Chemical shift assignments and secondary structure of the surrogate domain for drug discovery studies of human heparanase

    Biomolecular NMR Assignments, Vol. 9, Núm. 1, pp. 15-19

  2. In vivo detection of perinatal brain metabolite changes in a rabbit model of intrauterine growth restriction (IUGR)

    PLoS ONE, Vol. 10, Núm. 7

2014

  1. Apaf-1 inhibitors protect from unwanted cell death in In vivo models of kidney ischemia and chemotherapy induced ototoxicity

    PLoS ONE, Vol. 9, Núm. 10

  2. Dietary gallic acid and anthocyanin cytotoxicity on human fibrosarcoma HT1080 cells. A study on the mode of action

    Food and Function, Vol. 5, Núm. 2, pp. 381-389

  3. New clicked thiirane derivatives as gelatinase inhibitors: The relevance of the P1′ segment

    RSC Advances, Vol. 4, Núm. 34, pp. 17726-17735

2013

  1. Hit identification of novel heparanase inhibitors by structure- and ligand-based approaches

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 7, pp. 1944-1951

  2. Metabolomic profile of umbilical cord blood plasma from early and late intrauterine growth restricted (IUGR) neonates with and without signs of brain vasodilation

    PLoS ONE, Vol. 8, Núm. 12

  3. Progress towards water-soluble triazole-based selective MMP-2 inhibitors

    Organic and Biomolecular Chemistry, Vol. 11, Núm. 38, pp. 6623-6641

  4. Synthesis of fucosyl-N-Acetylglucosamine disaccharides by transfucosylation using α-L-Fucosidases from Lactobacillus casei

    Applied and Environmental Microbiology, Vol. 79, Núm. 12, pp. 3847-3850

2012

  1. Identification of first proadrenomedullin N-terminal 20 peptide (PAMP) modulator by means of virtual screening and NMR interaction experiments

    European Journal of Medicinal Chemistry, Vol. 55, pp. 262-272

  2. Novel compounds produced by Streptomyces lydicus NRRL 2433 engineered mutants altered in the biosynthesis of streptolydigin

    Journal of Antibiotics, Vol. 65, Núm. 7, pp. 341-348

2011

  1. Amino acid precursor supply in the biosynthesis of the RNA polymerase inhibitor streptolydigin by Streptomyces lydicus

    Journal of Bacteriology, Vol. 193, Núm. 16, pp. 4214-4223

  2. Biosynthesis of the RNA polymerase inhibitor streptolydigin in Streptomyces lydicus: Tailoring modification of 3-methyl-aspartate

    Journal of Bacteriology, Vol. 193, Núm. 10, pp. 2647-2651

  3. Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain

    Apoptosis, Vol. 16, Núm. 5, pp. 460-467

  4. Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1

    Human Molecular Genetics, Vol. 20, Núm. 18, pp. 3545-3553

  5. NMR structure and dynamics of recombinant wild type and mutated jerdostatin, a selective inhibitor of integrin α 1β 1

    Proteins: Structure, Function and Bioinformatics, Vol. 79, Núm. 8, pp. 2530-2542

  6. Polymer coiled-coil conjugates: Potential for development as a new class of therapeutic "molecular Switch"

    Biomacromolecules, Vol. 12, Núm. 1, pp. 19-27

  7. Potent "clicked" MMP2 inhibitors: Synthesis, molecular modeling and biological exploration

    Organic and Biomolecular Chemistry, Vol. 9, Núm. 12, pp. 4587-4599

  8. Production of heparanase constructs suitable for nuclear magnetic resonance and drug discovery studies

    Biopolymers, Vol. 95, Núm. 2, pp. 151-160

2010

  1. Contributions of computational chemistry and biophysical techniques to fragment-based drug discovery

    Current Medicinal Chemistry, Vol. 17, Núm. 17, pp. 1769-1794